Canadian Agency for Drugs and Technologies in Health, & Canadian Diabetes Association. (2017). Patient group input submissions: Empagliflozin and metformin (Synjardy) for diabetes mellitus (Type 2). Ottawa (ON): CADTH.
Chicago Style CitationCanadian Agency for Drugs and Technologies in Health, and Canadian Diabetes Association. Patient Group Input Submissions: Empagliflozin and Metformin (Synjardy) for Diabetes Mellitus (Type 2). Ottawa (ON): CADTH, 2017.
MLA CitationCanadian Agency for Drugs and Technologies in Health, and Canadian Diabetes Association. Patient Group Input Submissions: Empagliflozin and Metformin (Synjardy) for Diabetes Mellitus (Type 2). Ottawa (ON): CADTH, 2017.
Warning: These citations may not always be 100% accurate.